BD Prepares To Separate from Biosciences And Diagnostics Division

 
• By Elizabeth Orr

BD plans to separate its biosciences and diagnostics division into a new business to enhance strategic focus and growth. The move, which has been approved by the board, is expected to go forward sometime in 2026.

Businessman separating wooden blocks with money designs.
(Andrii Yalanskyi/Shutterstock)

More from Medtech Insight

More from Device Area